Everyone infected with a life-threatening pathogen deserves a treatment.
EmitBio™ is a life science company developing breakthrough medical devices that change how the world treats respiratory infectious disease.
EmitBio™ was formed by a team of individuals with decades of successful research, product development, and large-scale manufacturing experience across the life science and light science industries
Where Light meets Life™.
EmitBio has discovered how to use precise, monochromatic wavelengths of non-UV light to eliminate invading pathogens and stimulate host defense in the body — effectively creating an antiviral environment.
See how EmitBio treats COVID-19.
Mutation resilient: The treatment is not designed to be dependent on a specific SARS-CoV-2 genetic code or configuration of spike protein. The EmitBio approach has the potential to be effective regardless of viral mutations or future genetic drift.Watch The Video >
Help your body win the fight against COVID-19.
Your body is under constant attack from airborne bacteria, fungi, and viruses. Every breath takes in life-giving oxygen—and whatever else is floating around out there. Your immune system recognizes many of these intruders and responds to prevent or reduce infection. But when faced with a novel and especially virulent pathogen like the SARS-CoV-2, the coronavirus that causes COVID-19, we need reinforcements.
Helping to fight the pandemic.
The fastest way to stop the spread of COVID-19 is by quickly reducing the virus in those who have it, and stopping the spread to others. How do we protect ourselves against its relentless reach and mutations? EmitBio believes that elimination of the virus is best achieved through both vaccinations and treatments for those who have not received the vaccine or for whom it was ineffective.
Everyone deserves treatment.
EmitBio has been working towards this fundamental principle: “Everyone with COVID-deserves a treatment option.” Currently, treatments have only been authorized for those at high-risk and for those who are already hospitalized. This infection can progress quickly even if the patient is not considered “high-risk.” Anyone who tests positive can still put others at risk, even when quarantine protocols are followed. To break the cycle and stop the pandemic we must provide treatment for all.
EmitBio has developed a transformational treatment.* We’re taking the fight to COVID-19.
The body’s upper respiratory tract is the entry point for airborne pathogens. In clinical trials, EmitBio found that by directing safe, visible light to the pharynx (back of throat), subjects with mild-to-moderate COVID-19 infections experienced a 99.9% reduction of SARS-CoV-2 mean viral load.
Additionally, the amount of virus measured continued to drop even after the light treatments had stopped and the duration of illness was shortened by over 48 hours.
*The EmitBio device is investigational and not currently available for sale.